Disposition of Inventories of Products. Following termination of this Agreement with respect to one or more Pfizer Targets, Pfizer, its Affiliates and its Sublicensees will have the right to continue to sell their existing inventories of Pfizer Licensed Product(s) Targeting such Pfizer Targets that have received Regulatory Approval prior to such termination for a period not to exceed [***] after the effective date of such termination or expiration and Pfizer will pay any royalties payable in connection with such sales in accordance with Section 5.5.
Appears in 2 contracts
Samples: Research Collaboration and License Agreement (Allogene Therapeutics, Inc.), Research Collaboration and License Agreement (Cellectis S.A.)
Disposition of Inventories of Products. Following termination of this Agreement with respect to one or more Pfizer Research Project Targets, Pfizer, its Affiliates and its Sublicensees will shall have the right to continue to sell their existing inventories of Pfizer Licensed Product(s) Targeting such Pfizer Research Project Targets that have received Regulatory Marketing Approval prior to such termination for a period not to exceed [***] six (6) months after the effective date of such termination or expiration and Pfizer will shall pay any royalties payable in connection with such sales in accordance with Section 5.5.
Appears in 2 contracts
Samples: Option and License Agreement (CytomX Therapeutics, Inc.), Option and License Agreement (CytomX Therapeutics, Inc.)
Disposition of Inventories of Products. Following termination of this Agreement with respect to one or more Pfizer Research Project Targets, Pfizer, its Affiliates and its Sublicensees will shall have the right to continue to sell their existing inventories of Pfizer Licensed Product(s) Targeting such Pfizer Research Project Targets that have received Regulatory Marketing Approval prior to such termination for a period not to exceed [***] after the effective date of such termination or expiration and Pfizer will shall pay any royalties payable in connection with such sales in accordance with Section 5.5.
Appears in 1 contract
Samples: Option and License Agreement (CytomX Therapeutics, Inc.)